Powder: -20°C for 3 years
In solvent: -80°C for 2 years
AWL-II-38.3 is a potent ephrin-A receptor (EphA3) kinase inhibitor. AWL-II-38.3 does not exhibit significant cellular activity against Src-family kinases nor against b-raf [1] [2].
Description | AWL-II-38.3 is a potent ephrin-A receptor (EphA3) kinase inhibitor. AWL-II-38.3 does not exhibit significant cellular activity against Src-family kinases nor against b-raf [1] [2]. |
In vitro | AWL-II-38.3 fits to LIMK2 and LIMK1 ATP-binding and substrate-binding pockets [2] . |
Molecular Weight | 469.424 |
Formula | C23H18F3N5O3 |
CAS No. | 1135205-94-5 |
Powder: -20°C for 3 years
In solvent: -80°C for 2 years
DMSO: 65 mg/mL (138.47 mM), Need ultrasonic
( < 1 mg/ml refers to the product slightly soluble or insoluble )
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
AWL-II-38.3 1135205-94-5 蛋白酪氨酸激酶 Ephrin Receptor inhibit AWL II 38.3 LIMK1 Inhibitor LIMK2 EphA3 ATP AWLII38.3 inhibitor